Search

Author/Creator Chen, L -T

1. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. (22nd November 2018)

Authors:
Muro, K; Van Cutsem, E; Narita, Y; Pentheroudakis, G; Baba, E; Li, J; Ryu, M -H; Zamaniah, W I Wan; Yong, W -P; Yeh, K -H; Kato, K; Lu, Z; Cho, B C; Nor, I M; Ng, M; Chen, L -T; Nakajima, T E; Shitara, K; Kawakami, H; Tsushima, T
Journal:
Annals of oncology
Issue:
Volume 30:Number 1(2019)
Page Start:
19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. (22nd November 2018)

Authors:
Muro, K; Lordick, F; Tsushima, T; Pentheroudakis, G; Baba, E; Lu, Z; Cho, B C; Nor, I M; Ng, M; Chen, L -T; Kato, K; Li, J; Ryu, M -H; Zamaniah, W I Wan; Yong, W -P; Yeh, K -H; Nakajima, T E; Shitara, K; Kawakami, H; Narita, Y
Journal:
Annals of oncology
Issue:
Volume 30:Number 1(2019)
Page Start:
34
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS. (16th November 2017)

Authors:
Yoshino, T; Arnold, D; Taniguchi, H; Pentheroudakis, G; Yamazaki, K; Xu, R -H; Kim, T W; Ismail, F; Tan, I B; Yeh, K -H; Grothey, A; Zhang, S; Ahn, J B; Mastura, M Y; Chong, D; Chen, L -T; Kopetz, S; Eguchi-Nakajima, T; Ebi, H; Ohtsu, A
Journal:
Annals of oncology
Issue:
Volume 29:Number 1(2018)
Page Start:
44
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma. (5th April 2018)

Authors:
Abou-Alfa, G K; Qin, S; Ryoo, B -Y; Lu, S -N; Yen, C -J; Feng, Y -H; Lim, H Y; Izzo, F; Colombo, M; Sarker, D; Bolondi, L; Vaccaro, G; Harris, W P; Chen, Z; Hubner, R A; Meyer, T; Sun, W; Harding, J J; Hollywood, E M; Ma, J
Journal:
Annals of oncology
Issue:
Volume 29:Number 6(2018)
Page Start:
1402
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4). (19th December 2018)

Authors:
Boku, N; Ryu, M -H; Kato, K; Chung, H C; Minashi, K; Lee, K -W; Cho, H; Kang, W K; Komatsu, Y; Tsuda, M; Yamaguchi, K; Hara, H; Fumita, S; Azuma, M; Chen, L -T; Kang, Y -K
Journal:
Annals of oncology
Issue:
Volume 30:Number 2(2019)
Page Start:
250
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗